Recent studies demonstrated that GATA3 suppressed breast cancer dissemination from the primary site by inhibiting epithelial-to-mesenchymal transition (EMT) and alterations of the tumor microenvironment, such as angiogenesis, collagen remodeling, and proteolysis 9-11. Here, GATA3 is linked to breast carcinoma.